Evidence map›Paper›PMID 34162837›Full record

ArticleNature communications2021

Single cell derived mRNA signals across human kidney tumors.

Matthew D Young, Thomas J Mitchell, Lars Custers, Thanasis Margaritis, Francisco Morales-Rodriguez, Kwasi Kwakwa, Eleonora Khabirova, Gerda Kildisiute, Thomas R W Oliver, Ronald R de Krijger and 35 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. celltypeEnrich: a consensus-based scRNA-seq cluster annotation tool.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 13 institutions in 5 countries.

Matthew D Young *Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. my4@sanger.ac.uk.ORCID 0000-0003-0937-5290
Thomas J Mitchell *Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0003-0761-9503
Lars Custers *Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0003-0252-7714
Thanasis MargaritisPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Francisco Morales-RodriguezPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Kwasi KwakwaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Eleonora KhabirovaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-5891-6789
Gerda KildisiuteWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-5314-2294
Thomas R W OliverWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0003-4306-0102
Ronald R de KrijgerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0002-7760-879X
Federico ComitaniProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.ORCID 0000-0003-3226-1179
Alice PiapiUCL Great Ormond Street Hospital Institute of Child Health, London, UK.ORCID 0000-0001-8251-3309
Eva Bugallo-BlancoUCL Great Ormond Street Hospital Institute of Child Health, London, UK.
Christine ThevanesanUCL Great Ormond Street Hospital Institute of Child Health, London, UK.
Christina BurkeUCL Great Ormond Street Hospital Institute of Child Health, London, UK.ORCID 0000-0001-5381-3185
Elena PrigmoreWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Kirsty AmbridgeWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Kenny RobertsWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-6155-0821
Felipe A Vieira BragaAmsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Tim H H CoorensWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-5826-3554
Ignacio Del ValleUCL Great Ormond Street Hospital Institute of Child Health, London, UK.
Anna Wilbrey-ClarkWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Lira MamanovaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0003-1463-8622
Grant D StewartCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0003-3188-9140
Vincent J GnanapragasamCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Dyanne RamplingGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Neil SebireNIHR Great Ormond Street Hospital BRC and Institute of Child Health, London, UK.
Nicholas ColemanCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Liz HookCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Anne WarrenCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-1170-7867
Muzlifah HaniffaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-3927-2084
Marcel KoolPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Stefan M PfisterHopp Children´s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
John C AchermannUCL Great Ormond Street Hospital Institute of Child Health, London, UK.ORCID 0000-0001-8787-6272
Xiaoling HeMRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Roger A BarkerMRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Adam ShlienProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Omer A BayraktarWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-6055-277X
Sarah A TeichmannWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-6294-6366
Frank C HolstegePrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0002-8090-5146
Kerstin B MeyerWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-5906-1498
Jarno DrostPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.drost@prinsesmaximacentrum.nl.ORCID 0000-0002-2941-6179
Karin StraathofUCL Great Ormond Street Hospital Institute of Child Health, London, UK. k.straathof@ucl.ac.uk.ORCID 0000-0001-9673-8568
Sam BehjatiWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. sb31@sanger.ac.uk.ORCID 0000-0002-6600-7665
Wellcome Sanger Institute · GBGreat Ormond Street Hospital · GBUniversity of Cambridge · GBOncode Institute · NLPrincess Máxima Center · NLCambridge University Hospitals NHS Foundation Trust · GBGerman Cancer Research Center · DEWellcome/MRC Cambridge Stem Cell Institute · GBAmsterdam University Medical Centers · NLGreat Ormond Street Hospital for Children NHS Foundation Trust · GBHospital for Sick Children · CAUniversity Medical Center Utrecht · NLUniversity of Toronto · CA

Funding

Cancer Research UK 27176Cancer Research UK C9685/A25117Department of HealthMedical Research Council MC_PC_17230Wellcome TrustWellcome Trust 209328/Z/17/ZWellcome Trust 211276/Z/18/Z
6 · The paper itself

Abstract

Tumor cells may share some patterns of gene expression with their cell of origin, providing clues into the differentiation state and origin of cancer. Here, we study the differentiation state and cellular origin of 1300 childhood and adult kidney tumors. Using single cell mRNA reference maps of normal tissues, we quantify reference "cellular signals" in each tumor. Quantifying global differentiation, we find that childhood tumors exhibit fetal cellular signals, replacing the presumption of "fetalness" with a quantitative measure of immaturity. By contrast, in adult cancers our assessment refutes the suggestion of dedifferentiation towards a fetal state in most cases. We find an intimate connection between developmental mesenchymal populations and childhood renal tumors. We demonstrate the diagnostic potential of our approach with a case study of a cryptic renal tumor. Our findings provide a cellular definition of human renal tumors through an approach that is broadly applicable to human cancer.

Indexed as

TranscriptomeAdultAlgorithmsChildFetusGene Expression Regulation, DevelopmentalHumansKidneyKidney NeoplasmsModels, GeneticRNA, MessengerRNA-SeqSignal TransductionSingle-Cell AnalysisRNA, Messenger

Identifiers

PMID34162837
PMCPMC8222373
OpenAlexW3174638849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.